Atherosclerosis

Rediff.com » News » Atherosclerosis

News for Atherosclerosis

News
Business

How To Be Aware About Early Heart Disease

'Thirty per cent of the world's deaths in young people, due to heart disease, are Indians.' IMAGE: Kindly note the image has been posted only for representational purposes. Photograph: Kind......

Study reveals how COVID-19 damages heart

Researchers have discovered how COVID-19 infection damages the heart tissue, paving the way for better treatments for the condition. Kindly note that this image has been posted for......

Smoking increases your coronavirus risk

'Smokers are a highly susceptible population during this pandemic.''Health benefits from quitting smoking can start as early as within an hour.' IMAGE: A man smokes a cigarette whilst wearing a......

Scientists identify 6 potential drugs for COVID-19

Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19. The research, published in the journal Nature, tested the efficacy of approved drugs,......

Now, surgery to fix high blood pressure

The doctor, who was part of a team that brought path-breaking surgery to Canada, in conversation with Ajit Jain Three specialists performed ground-breaking surgery at the Peter Munk Cardiac Center,......

Dr Reddy's bets big on drug discovery

Dr Reddy's Laboratories hopes to become a true drug discovery company in the near future, said chairman K Anji Reddy and chief executive officer GV Prasad at the 24th annual general body meeting in......

Dr Reddy's starts 1st clinical trial in Europe

Dr Reddy's Laboratories on Monday said it has, for the first time, started testing a drug in Europe with the initiation of Phase I clinical trials for its cardiovascular drug candidate RUS 3108 in......

Diabetes: India faces economic burden

The number of diabetic patients in the country, which was 31.7 million 2000, is expected to shoot up to 79.4 million by the year 2030, according to the World Health Organisation.India is followed......

Biocon hits big time in US with lovastatin

Bangalore-based Biocon India has managed to garner a 10 per cent market share of the cholesterol lowering drug lovastatin in the United States in less than six months of its launch.The company is......

Rediff News

Atherosclerosis

News for Atherosclerosis

How To Be Aware About Early Heart Disease

Study reveals how COVID-19 damages heart

Smoking increases your coronavirus risk

Scientists identify 6 potential drugs for COVID-19

Now, surgery to fix high blood pressure

Dr Reddy's bets big on drug discovery

Dr Reddy's starts 1st clinical trial in Europe

Diabetes: India faces economic burden

Biocon hits big time in US with lovastatin

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS